Contact Us - Novocure

about us

corporate timeline Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.

leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.

corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
our therapy

mechanism of action Our proprietary technology – Tumor Treating Fields – disrupts cell division through physical interactions with key molecules during mitosis.

delivery method We deliver Tumor Treating Fields through a noninvasive, portable medical device that targets solid tumors with no known systemic toxicities.

treating cancer with electric fields Treatment with Tumor Treating Fields has become a fourth modality in cancer care.
our pipeline

clinical trials Our mechanism of action is broadly applicable across a variety of solid tumors.

publications We have more than 15 years of research and multiple peer-reviewed publications with pre-clinical data in 15 cancer types and clinical data in eight cancer types.

novocuretrial.com The science of Tumor Treating Fields extends beyond glioblastoma. We are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.
patient-forward
news and media

media gallery

Featured Stories
investor relations

press releases

corporate presentation

events

annual reports

sec filings

stock information

corporate governance

faq

email alerts

NASDAQ: current stock price

15.80

0.95

last update 6/19/2017 12:00AM
careers

working with us

our locations

current job listings

contact Novocure

Thank you for your interest in Novocure. Please complete and submit the contact form, or use the directory below to find a specific department or location.

global
locations

Corporate Office

Le Masurier House
La Rue Le Masurier
St. Helier JE2 4YE
Jersey Isle

US Operations

195 Commerce Way
Portsmouth, NH 03801

20 Valley Stream Parkway
Suite 300
Malvern, PA 19355

1500 Broadway, 17th Floor
New York, NY 10036

European Operations

Novocure GmbH
Park 6
CH-6039 Root D4
Switzerland

Novocure GmbH
Elektrastrasse 6
81925 München
Germany

Japanese Operations

The Gran Tokyo North Tower
36th Floor
1-9-1 Marunouchi, Chiyoda-ku
Tokyo 100-6736
Japan

Israel Operations

Topaz Building
4th Floor
MATAM Center
PO Box 15022
Sha’ar HaCarmel
Haifa 31905
Israel

about us
- corporate timeline Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.
- leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
- corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
our therapy
- mechanism of action Our proprietary technology – Tumor Treating Fields – disrupts cell division through physical interactions with key molecules during mitosis.
- delivery method We deliver Tumor Treating Fields through a noninvasive, portable medical device that targets solid tumors with no known systemic toxicities.
- treating cancer with electric fields Treatment with Tumor Treating Fields has become a fourth modality in cancer care.
our pipeline
- clinical trials Our mechanism of action is broadly applicable across a variety of solid tumors.
- publications We have more than 15 years of research and multiple peer-reviewed publications with pre-clinical data in 15 cancer types and clinical data in eight cancer types.
- novocuretrial.com The science of Tumor Treating Fields extends beyond glioblastoma. We are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.
patient-forward
news and media
- media gallery
- Featured Stories
investor relations
careers

contact Novocure

General

Clinical Trial Information

Physicians and Healthcare Professionals

Media

Investors

Grants, Charitable Contributions and Sponsorships

Careers